Remco de Bree

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

David R. Colnot, Jan C. Roos, Remco de Bree et al. · Cancer Immunology Immunotherapy · 2003 · 69 citations · Full text

Malignant Disease, Squamous Cell Carcinoma, Medicine +8

What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010?

Francisco Civantos, Sandro J. Stoeckli, Robert P. Takes et al. · European Archives of Oto-Rhino-Laryngology · 2010 · 60 citations · Full text

Cost–utility of sentinel lymph node biopsy in cT1–T2N0 oral cancer

Naomi van der Linden, Géke B. Flach, Remco de Bree et al. · Oral Oncology · 2015 · 38 citations · Full text

Ct1–t2n0 Oral Cancer, Cancer Detection, Medicine +5

Management of the clinically node negative neck in squamous cell carcinoma of the maxilla

Michiel H. M. A. Joosten, Remco de Bree, Ellen M. Van Cann · Oral Oncology · 2017 · 25 citations · Full text

Nasolacrimal duct obstruction caused by an oncocytoma.

Remco de Bree, Robert A Scheeren, Allain Kummer et al. · PubMed · 2002 · 14 citations

Oculoplastics, Surgical Pathology, Histopathology +8